Posts by: Vijaya Iyer

News

Sickle cell disease patients experience silent strokes in the deep white matter of the brain that is prone to low oxygen supply, a brain-mapping study shows. The study, “Silent ... Read more

November 20, 2018November 20, 2018

New Tool Helps Primary Care Physicians Provide Better Care for SCD Patients, Study Shows

News

A new clinical decision support-based tool can help primary care physicians improve the care and management of patients with sickle cell disease (SCD), a study reports. The study, “Effectiveness of ... Read more

November 1, 2018November 1, 2018

Virtual Reality Program May Provide Effective Relief From Pain for SCD Patients, Study Suggests

News

A virtual reality program designed to provide a distraction from pain may be an effective complementary therapy for children who are hospitalized for a sickle cell crisis, a study shows. ... Read more

October 25, 2018October 25, 2018

HemoType SC is a Fast, Inexpensive Diagnostic Tool for Sickle Cell Disease Screening, Study Shows

News

The diagnostic test HemoType SC is a viable option for the highly sensitive, specific, inexpensive, and rapid diagnosis of sickle cell disease, a large multi-center study shows. The test can ... Read more

October 23, 2018October 23, 2018

Marijuana Use Common in Sickle Cell Patients, Highlighting Need for More Research, Study Shows

News

Many sickle cell disease (SCD) patients use marijuana for its medicinal benefits, according to an anonymous survey by researchers from Yale New Haven Hospital and Yale University. These results show that there ... Read more

October 16, 2018October 16, 2018

Multi-Organization Partnership to Encourage Blood Donation and SCD Awareness

News

A five-year partnership among The Sickle Cell Disease Association of America (SCDAA), the Sickle Cell Foundation of Georgia (SCFG), and the American Red Cross has been launched to encourage blood donation, ... Read more

October 11, 2018October 11, 2018

Agreement With Cardinal Health Widens Distribution of Endari for Emmaus

News

A major distribution agreement with Cardinal Health will make Endari (L-glutamine) available in pharmacies nationwide that use Cardinal as their supplier, Emmaus Life Sciences announced. Already available to sickle cell disease ... Read more

September 18, 2018September 18, 2018

Sickle Cell Patients in UK Survey, Especially Those 16 to 20, Voice Problems with Care and Pain Relief Given

News

In a survey, patients across the U.K. with sickle cell disease — especially adolescents and young adults — voiced discontent with their healthcare experiences, particularly as they relate to emergency care and the ... Read more

September 6, 2018September 6, 2018

GlycA Seen as Not a Good Indicator of Inflammation in SCD Patients, Study Shows

News

GlycA, a biomarker for conditions linked to vascular inflammation, has been found to not be a reliable indicator of inflammation in patients with sickle cell disease (SCD) due to its inability ... Read more

August 2, 2018August 2, 2018

Endari Will Soon Be Available to Sickle Cell Patients in the US Military

News

The oral therapy Endari (L-glutamine), developed by Emmaus Life Sciences, will soon be made available to patients with sickle cell disease in the United States military, along with 9.4 ... Read more

Posts by: Vijaya Iyer

Vijaya Iyer

Low Oxygen Regions in Brains of Sickle Cell Patients are Prone to Small Strokes, Study Shows

New Tool Helps Primary Care Physicians Provide Better Care for SCD Patients, Study Shows

Virtual Reality Program May Provide Effective Relief From Pain for SCD Patients, Study Suggests

HemoType SC is a Fast, Inexpensive Diagnostic Tool for Sickle Cell Disease Screening, Study Shows

Marijuana Use Common in Sickle Cell Patients, Highlighting Need for More Research, Study Shows

Multi-Organization Partnership to Encourage Blood Donation and SCD Awareness

Agreement With Cardinal Health Widens Distribution of Endari for Emmaus

Sickle Cell Patients in UK Survey, Especially Those 16 to 20, Voice Problems with Care and Pain Relief Given

GlycA Seen as Not a Good Indicator of Inflammation in SCD Patients, Study Shows

Endari Will Soon Be Available to Sickle Cell Patients in the US Military

Pin It on Pinterest